|
|
|
|
|
|
by comstock
3056 days ago
|
|
|
Yes, but I would say quality is most important in almost all cases. Well, quality being defined as <1% error rate, which isn’t such a high bar. The most compelling near term applications (NITP etc) use fragmented DNA, and long reads will have no benefit here. So, yes. Long reads are useful, but you need to have at least reasonable performance in other respects. The same thing has been seen with PacBio, who have not played well in the market, despite having a read length advantage. |
|
|